These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29247128)

  • 1. Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand.
    Gosling AL; Boocock J; Dalbeth N; Harré Hindmarsh J; Stamp LK; Stahl EA; Choi HK; Matisoo-Smith EA; Merriman TR
    Ann Rheum Dis; 2018 Apr; 77(4):571-578. PubMed ID: 29247128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout.
    McKinney C; Stamp LK; Dalbeth N; Topless RK; Day RO; Kannangara DR; Williams KM; Janssen M; Jansen TL; Joosten LA; Radstake TR; Riches PL; Tausche AK; Lioté F; So A; Merriman TR
    Arthritis Res Ther; 2015 Oct; 17():288. PubMed ID: 26462562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-Specific Resequencing Associates the ATP-Binding Cassette Subfamily C Member 4 Gene With Gout in New Zealand Māori and Pacific Men.
    Tanner C; Boocock J; Stahl EA; Dobbyn A; Mandal AK; Cadzow M; Phipps-Green AJ; Topless RK; Hindmarsh JH; Stamp LK; Dalbeth N; Choi HK; Mount DB; Merriman TR
    Arthritis Rheumatol; 2017 Jul; 69(7):1461-1469. PubMed ID: 28371506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aotearoa New Zealand Māori and Pacific Population-amplified Gout Risk Variants:
    Ji A; Shaukat A; Takei R; Bixley M; Cadzow M; Topless RK; Major TJ; Phipps-Green A; Merriman ME; Hindmarsh JH; Stamp LK; Dalbeth N; Li C; Merriman TR
    J Rheumatol; 2021 Nov; 48(11):1736-1744. PubMed ID: 34210831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets.
    Phipps-Green AJ; Hollis-Moffatt JE; Dalbeth N; Merriman ME; Topless R; Gow PJ; Harrison AA; Highton J; Jones PB; Stamp LK; Merriman TR
    Hum Mol Genet; 2010 Dec; 19(24):4813-9. PubMed ID: 20858603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets.
    Hollis-Moffatt JE; Xu X; Dalbeth N; Merriman ME; Topless R; Waddell C; Gow PJ; Harrison AA; Highton J; Jones PB; Stamp LK; Merriman TR
    Arthritis Rheum; 2009 Nov; 60(11):3485-92. PubMed ID: 19877038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National prevalence of gout derived from administrative health data in Aotearoa New Zealand.
    Winnard D; Wright C; Taylor WJ; Jackson G; Te Karu L; Gow PJ; Arroll B; Thornley S; Gribben B; Dalbeth N
    Rheumatology (Oxford); 2012 May; 51(5):901-9. PubMed ID: 22253023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Polynesian-specific copy number variant encompassing the MICA gene associates with gout.
    Wang K; Cadzow M; Bixley M; Leask MP; Merriman ME; Yang Q; Li Z; Takei R; Phipps-Green A; Major TJ; Topless R; Dalbeth N; King F; Murphy R; Stamp LK; de Zoysa J; Wang Z; Shi Y; Merriman TR
    Hum Mol Genet; 2022 Oct; 31(21):3757-3768. PubMed ID: 35451026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and gout.
    Fatima T; Altaf S; Phipps-Green A; Topless R; Flynn TJ; Stamp LK; Dalbeth N; Merriman TR
    Rheumatol Int; 2016 Feb; 36(2):255-61. PubMed ID: 26410617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects.
    Flynn TJ; Phipps-Green A; Hollis-Moffatt JE; Merriman ME; Topless R; Montgomery G; Chapman B; Stamp LK; Dalbeth N; Merriman TR
    Arthritis Res Ther; 2013; 15(6):R220. PubMed ID: 24360580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand.
    Krishnan M; Major TJ; Topless RK; Dewes O; Yu L; Thompson JMD; McCowan L; de Zoysa J; Stamp LK; Dalbeth N; Harré Hindmarsh J; Rapana N; Deka R; Eng WWH; Weeks DE; Minster RL; McGarvey ST; Viali S; Naseri T; Sefuiva Reupena M; Wilcox P; Grattan D; Shepherd PR; Shelling AN; Murphy R; Merriman TR
    Diabetologia; 2018 Jul; 61(7):1603-1613. PubMed ID: 29721634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The experience and impact of gout in Māori and Pacific people: a prospective observational study.
    Dalbeth N; House ME; Horne A; Te Karu L; Petrie KJ; McQueen FM; Taylor WJ
    Clin Rheumatol; 2013 Feb; 32(2):247-51. PubMed ID: 23114632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity.
    Hollis-Moffatt JE; Gow PJ; Harrison AA; Highton J; Jones PB; Stamp LK; Dalbeth N; Merriman TR
    Arthritis Res Ther; 2011 Jun; 13(3):R85. PubMed ID: 21658257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol.
    Ofanoa M; Ofanoa SM; Heather M; Tu'akoi S; Lutui H; Dalbeth N; Grey C; van der Werf B; Goodyear-Smith F
    Int J Equity Health; 2021 Dec; 20(1):262. PubMed ID: 34949187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardio-metabolic disease genetic risk factors among Māori and Pacific Island people in Aotearoa New Zealand: current state of knowledge and future directions.
    Merriman TR; Wilcox PL
    Ann Hum Biol; 2018 May; 45(3):202-214. PubMed ID: 29877153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitating equitable prevention and management of gout for Māori in Northland, New Zealand, through a collaborative primary care approach.
    Lawrence A; Scott S; Saparelli F; Greville G; Miller A; Taylor A; Gow P
    J Prim Health Care; 2019 Jul; 11(2):117-127. PubMed ID: 32171354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricaemia and gout in New Zealand rural and urban Māori and non-Māori communities.
    Stamp LK; Wells JE; Pitama S; Faatoese A; Doughty RN; Whalley G; Richards AM; Cameron VA
    Intern Med J; 2013 Jun; 43(6):678-84. PubMed ID: 23279108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human evolution in Polynesia.
    Whyte AL; Marshall SJ; Chambers GK
    Hum Biol; 2005 Apr; 77(2):157-77. PubMed ID: 16201134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of direct evidence for natural selection at the candidate thrifty gene locus, PPARGC1A.
    Cadzow M; Merriman TR; Boocock J; Dalbeth N; Stamp LK; Black MA; Visscher PM; Wilcox PL
    BMC Med Genet; 2016 Nov; 17(1):80. PubMed ID: 27846814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-specific association between ABCG2 variants and tophaceous disease in people with gout.
    He W; Phipps-Green A; Stamp LK; Merriman TR; Dalbeth N
    Arthritis Res Ther; 2017 Mar; 19(1):43. PubMed ID: 28270222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.